This titrate-up and taper-down controversy stems from concerns regarding the potential for hyperglycemia upon initiation of total parenteral nutrition (TPN) and for hypoglycemia upon discontinuation.
Am J Health Syst Pharm. 2005;62(21):2260-2264. Verify that the patient is receiving some source of exogenous glucose before initiating infusion (e.g., total parenteral nutrition [TPN], i.v. fluids ...
RANCHO CUCAMONGA, Calif., March 29, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the U.S. Food and Drug Administration (“FDA”) approved the Company’s ...
Hikma is offering labetalol hydrochloride 1mg/mL in 200-ml dextrose injection and 100-, 200- and 300-mL in sodium chloride injection. Labetalol HCl in sodium chloride injection and labetalol HCl in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results